|
|
|
| home > news |
|
|
 INDUSTRY NEWS AND PRESS RELEASES |
|
|
The biotech company baseclick GmbH launched a new and highly efficient method for SARS-CoV-2 mutation analysis
The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7
in Great Britain and other countries shows changes in the genome of the
SARS-CoV-2 virus can lead to new biological properties. More>> |
|
|
Join Us In A New Free Webinar by Qloud
Our experience in qualifications has allowed us to
identify the necessary improvements for the resolution of data integrity
GAPs, and process optimization in regulated environments. More>> |
|
|
PHASTAR Announces Investment by Charterhouse Capital Partners
Funding will Support Expansion of Statistics and Data Science Services and Geographic Reach
PHASTAR, a specialist biometrics clinical research organization (CRO)
for clinical trials, announces an investment made by Charterhouse
Capital Partners LLP, a long-established European private equity firm,
which will support PHASTAR’s growth in biometrics and geographic
expansion. Charterhouse is making its investment in partnership with
PHASTAR’s Founder and CEO Kevin Kane, who remains a significant
shareholder in the business. Kevin and the existing management team will
continue to run, manage and operate the business on a day-to-day basis.
More>> |
|
|
Calyx Supports Breakthrough Therapy Approvals for Oncology Treatments
Calyx Medical Imaging and other eClinical services provide critical support for clinical development programs to deliver much-needed therapies to market
Calyx, the eClinical and regulatory solutions and services provider most
relied on for solving complex data challenges in clinical research,
today announced that its Medical Imaging and other eClinical solutions
supported half of the oncology treatments approved by the FDA as
Breakthrough Therapies in the past two years. More>> |
|
|
BIOGEN TO LAUNCH PIONEERING STUDY TO DEVELOP DIGITAL BIOMARKERS OF COGNITIVE HEALTH USING APPLE WATCH AND IPHONE
January 11, 2021 at 7:30 AM EST
The study aims to identify digital biomarkers to help monitor cognitive performance and health including potentially detecting mild cognitive impairment, an early indicator of certain forms of dementia such as Alzheimer’s disease
Cognitive health — the ability to think clearly, to learn and to remember — is an indicator of brain health and important to performing daily activities
More>> |
|
|
EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing
Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth
Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers
More>> |
|
|
Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases
Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth
Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers
More>> |
|
|
3P innovation Announces Transition to Employee Ownership
Award-winning, UK based engineering and process automation company, 3P
innovation Ltd, is proud to announce that it is now an employee-owned
company. This transition has been taken to secure its long-term future,
for the benefit of customers and employees alike. More>> |
|
|
Loftware and NiceLabel Combine, Extend Global Leadership in Enterprise Labeling and Artwork Management
Portsmouth, NH — January 12, 2021 – Loftware, Inc., the global
leader in Enterprise Labeling & Artwork Management Solutions and
NiceLabel, a leading developer of label management systems today
announced that they are combining under the Loftware corporate umbrella.
This union gives customers and partners an expanded choice of
solutions, while providing enhanced labeling capabilities and the
benefits of greater investment in cloud-based solutions and
technologies. It also brings together 60 years of combined expertise in
solving labeling challenges for companies of all sizes throughout a wide
range of industries across the globe. More>> |
|
|
Novasep to sell its chromatography equipment division to Sartorius
06 Jan 2021
• A disposal aligned with Novasep’s core strategy
• An opportunity for Novasep’s chromatography equipment division to accelerate its growth by joining an established leader in the sector
More>> |
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Peli BioThermal to Present at LogiPharma Europe
Peli BioThermal, the global name in temperature controlled packaging,
will be attending this year’s virtual LogiPharma Europe event and
highlight how products have been adapted to meet the rising requirements
of the pharmaceutical sector’s rapid response to the global pandemic.
More info >> |
|
 |
White Papers |
 |
|
Future-proofing serialization solutions: the importance of strong level 3 capabilities
Adents
The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >> |
|
 |
Industry Events |
 |
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
8-11 February 2021, Vienna, Austria
In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >> |
|
|
